ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 2 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,631,538 | -10.9% | 134,377 | +1.3% | 0.00% | 0.0% |
| Q2 2023 | $4,074,400 | +349.7% | 132,695 | +428.6% | 0.00% | +300.0% |
| Q1 2023 | $906,003 | -97.0% | 25,104 | -96.8% | 0.00% | -97.1% |
| Q4 2022 | $30,270,660 | +60.3% | 775,177 | +66.2% | 0.04% | +12.9% |
| Q3 2022 | $18,885,000 | +92.3% | 466,526 | +99.4% | 0.03% | +121.4% |
| Q2 2022 | $9,821,000 | +927.3% | 233,992 | +794.3% | 0.01% | +1300.0% |
| Q3 2021 | $956,000 | +36.6% | 26,164 | +54.4% | 0.00% | 0.0% |
| Q2 2021 | $700,000 | -22.1% | 16,947 | -7.6% | 0.00% | 0.0% |
| Q4 2020 | $899,000 | +247.1% | 18,341 | +204.0% | 0.00% | – |
| Q3 2020 | $259,000 | – | 6,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |